drugset / Trial / NCT00004866

DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix

NCT00004866

Phase 2 Completed Daiichi Sankyo
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of DX-8951f in treating women who have advanced or recurrent cancer of the cervix.

Timeline

Start
2000-01
Primary completion
2003-09
Completion
2003-09

Drugs

EvaluationDrugModalityDoseRoute
Subject exatecan Small molecule Intravenous

Indications